Digital AI in Drug Discovery: Day One There is no denying that artificial intelligence (AI) has captured the imagination of innovators working across the pharmaceutical sector.
Digital The next chapter for AI protein structure prediction When Alphabet announced in 2021 that its AlphaFold AI could predict the structure of almost
News FDA clears Viridian's Tepezza rival for thyroid eye disease Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
